StonvexLoading…
StonvexStonvexStonvexCore line items from CWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.67B | $2.54B | $10.29B | $7.37B | $4.77B |
Operating Income | Not available | $58.70M | $452.50M | $275.60M | $168.10M |
Net Income | Not available | $-12.60M | $88.20M | $110.60M | $59.20M |
EPS (Diluted) | $0.35 | $-0.05 | $0.38 | $0.47 | $0.25 |
Total Assets | Not available | $7.65B | $7.68B | $7.69B | $7.56B |
Total Liabilities | Not available | $5.70B | $5.72B | $5.73B | $5.65B |
Cash & Equivalents | Not available | $600.60M | $784.20M | $634.40M | $618.20M |
Free Cash Flow OCF − CapEx | Not available | $-255.70M | $293.00M | $58.70M | $-166.30M |
Shares Outstanding | Not available | 234.29M | 231.70M | 231.60M | 231.47M |